Panorama 3 investigates: tens of thousands join initiatives in Milan against Philips [VIDEO]

Panorama 3 investigates: tens of thousands join initiatives in Milan against Philips [VIDEO]
02/12/24, 11:00
The renowned investigative program Panorama 3 explores how approximately 30,000 people from Germany have decided to participate in the European process against Philips for damages from defective respiratory devices. The video is now available to European audiences with subtitles in these languages: DE, IT, EN, SP, FR.
Panorama 3 is one of the most effective investigative platforms in German journalism. In this episode, it delves into the growing legal battle against Philips. An investigation conducted by NDR reveals that nearly 30,000 people in Germany alone have expressed interest in participating in a European class action against the medical device manufacturer.
CPAP Europe, thanks to a team of native-speaking translators, now makes the video accessible to European audiences with subtitles in the following languages: DE, IT, EN, SP, FR.
The case revolves around the recall, which occurred in June 2021, of defective respiratory devices, more than a decade after the first serious incident was reported. These devices, designed to treat sleep apnea and other respiratory conditions, have raised serious health concerns.
German health insurance companies have recently informed their policyholders about available legal options, contributing to the expansion of interest in the Italian class action, the epicenter of the European procedure. The episode examines Philips' delayed response, the health and legal implications for patients, and the approaches of patients and health authorities towards the company.
With exclusive interviews with involved individuals, expert comments - including one of CPAP Europe's lawyers representing the affected parties in Milan - Panorama 3 provides a detailed look at this issue. Philips was invited to present their point of view but did not provide it.
The episode, produced by Brid Roesner, aired on December 3, 2024, at 21:15 with an 11-minute segment on the implications of the case for patients, healthcare system, and corporate responsibility.